These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9673748)
21. Does mycophenolate mofetil prevent extra-renal flares in systemic lupus erythematosus? Results from an observational study of patients in a single practice treated for up to 5 years. Posalski JD; Ishimori Ml; Wallace DJ; Weisman MH Lupus; 2009 May; 18(6):516-21. PubMed ID: 19395453 [TBL] [Abstract][Full Text] [Related]
22. Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients. Baudard M; Vincent A; Moreau P; Kergueris MF; Harousseau JL; Milpied N Bone Marrow Transplant; 2002 Sep; 30(5):287-95. PubMed ID: 12209350 [TBL] [Abstract][Full Text] [Related]
23. International variation in medication prescription rates among elderly patients with inflammatory bowel disease. Benchimol EI; Cook SF; Erichsen R; Long MD; Bernstein CN; Wong J; Carroll CF; Frøslev T; Sampson T; Kappelman MD J Crohns Colitis; 2013 Dec; 7(11):878-89. PubMed ID: 23018106 [TBL] [Abstract][Full Text] [Related]
24. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis]. Greiner K; Varikkara M; Santiago C; Forrester JV Ophthalmologe; 2002 Sep; 99(9):691-4. PubMed ID: 12219257 [TBL] [Abstract][Full Text] [Related]
34. Mycophenolate mofetil is effective and well tolerated in the treatment of refractory acute and chronic graft-versus-host disease. Takami A; Mochizuki K; Okumura H; Ito S; Suga Y; Yamazaki H; Yamazaki M; Kondo Y; Asakura H; Nakao S Int J Hematol; 2006 Jan; 83(1):80-5. PubMed ID: 16443558 [TBL] [Abstract][Full Text] [Related]
35. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up. Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777 [TBL] [Abstract][Full Text] [Related]
36. Mycophenolate mofetil treatment in conditions different from organ transplantation. Quiroz Y; Herrera-Acosta J; Johnson RJ; Rodriguez-Iturbe B Transplant Proc; 2002 Nov; 34(7):2523-6. PubMed ID: 12431510 [No Abstract] [Full Text] [Related]
37. Cryptosporidial infection in children with inflammatory bowel disease. Vadlamudi N; Maclin J; Dimmitt RA; Thame KA J Crohns Colitis; 2013 Oct; 7(9):e337-43. PubMed ID: 23415795 [TBL] [Abstract][Full Text] [Related]
38. Remission of severe relapsing or persistent lupus nephritis using mycophenolate mofetil. Flores-Suárez LF Arch Med Res; 2006 Jan; 37(1):68-73. PubMed ID: 16314189 [TBL] [Abstract][Full Text] [Related]
39. Cyclosporine therapy in inflammatory bowel disease: short-term and long-term results. Gurudu SR; Griffel LH; Gialanella RJ; Das KM J Clin Gastroenterol; 1999 Sep; 29(2):151-4. PubMed ID: 10478875 [TBL] [Abstract][Full Text] [Related]
40. [Mycophenolate mofetil--a new therapeutic agent for chronic autoimmune diseases]. Harboe E; Gøransson L; Wildhagen K; Omdal R Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1650-2. PubMed ID: 15976831 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]